⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Halo Life Science and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Halo Life Science
↗Austin, Texas, United States
Halo Life Science is a purpose-driven longevity and food technology company focused on restoring metabolic function and addressing chronic conditions. The company develops bioactive compounds, such as 'Naturalin,' designed for fortifying foods, nutraceuticals, supplements, and therapeutics.
Leveraging its proprietary 'IONx AI' platform, Halo Life Science aims to discover and optimize molecules that combat metabolic dysfunction, insulin resistance, and inflammation. The company's mission is to democratize health through accessible nutrition and improve the quality of life for the global 'diabesity' population.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:FoodTech / Longevity / Metabolic Health
SIZE & FINANCIALS
Employees:1-50
Founded:2015
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$0.1M
Investors:MassChallenge
PIPELINE
Stage:Discovery
Lead Drug Stage:Discovery/Preclinical
Modalities:Bioactive compounds, Nutraceuticals
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
Competitors:MannKind Corp, Corcept Therapeutics, Adocia
LEADERSHIP
Key Executives:
Michael Reyes - Founder & CEO
Brian Direen - CBO
Robert M. Cabrera, PhD - CSO
LINKS
Website:halolifescience.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Halo Life Science. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.